跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19 条关于
“C1INH”
全部
19
临床试验
8
药物
1
机构
0
资讯
10
去年
Pharvaris Advances Deucrictibant for HAE and AAE, Outlines 2025 Priorities
去年
FDA Accepts Donidalorsen NDA for Hereditary Angioedema Prophylaxis
去年
European Commission Grants Orphan Designation to Pharvaris' Deucrictibant for Bradykinin-Mediated Angioedema
9天前
Pharvaris's Oral Deucrictibant XR Cuts HAE Attack Rate 83% in Phase III CHAPTER-3
去年
Navenibart Shows Promise in Reducing Hereditary Angioedema Attacks in Phase 1b/2 Trial
去年
FDA Delays Sebetralstat Approval Decision for Hereditary Angioedema Treatment Due to Resource Constraints
2年前
KalVista Submits NDA to FDA for Oral Sebetralstat in Hereditary Angioedema
去年
KalVista to Present Sebetralstat Data at Major Medical Conferences as FDA Review Continues
11个月前
Pharming Group to Present 12 Studies on Rare Disease Treatments at 2025 ACAAI Meeting
去年
Donidalorsen Shows 62% Reduction in HAE Attacks When Patients Switch from Other Prophylactics in Phase 3 Study